| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T221 |
0-202 |
Sentence |
denotes |
Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . |
| TextSentencer_T221 |
0-202 |
Sentence |
denotes |
Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . |
| T75884 |
0-202 |
Sentence |
denotes |
Remyelination as Neuroprotection Using oligodendrocyte binding as a screening assay, we identified candidate human monoclonal antibodies that might also promote remyelination (Warrington et al., 2000) . |
| TextSentencer_T222 |
203-383 |
Sentence |
denotes |
Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody. |
| TextSentencer_T222 |
203-383 |
Sentence |
denotes |
Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody. |
| T37881 |
203-383 |
Sentence |
denotes |
Human monoclonal antibodies were isolated from patients with monoclonal gammopathy, a relatively common condition characterized by high concentrations of monoclonal serum antibody. |
